Article

A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen.

Dr Balabhai Nanavati Hospital and Research Center, Juhu, Bombay.
Indian Journal of Gastroenterology 02/1994; 13(1):7-8.
Source: PubMed

ABSTRACT There have been conflicting data in literature about the value of Phyllanthus amarus in treating hepatitis B virus-related disorders.
To evaluate the role of Phyllanthus amarus in eradication of the virus in hepatitis B carriers.
Phyllanthus amarus was administered to 30 asymptomatic carriers of hepatitis B surface antigen (HBsAg) in a dosage of 250 to 500 mg thrice daily for 4 to 8 weeks.
None of the 30 subjects cleared HBsAg. Phyllanthus amarus was well tolerated, with no clinical side effects or changes in the organ profiles for safety evaluation.
Phyllanthus amarus is not effective in clearing HBsAg in asymptomatic carriers of the antigen.

1 Follower
 · 
254 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Geraniin, an ellagitannin found abundantly in many fruits, nuts, traditional Chinese medicine (TCM) and ayurvedic herbs, has been reported to possess numerous health benefits. This is the first study that elucidates geraniin, purified from the sub-tropical fruit Nephelium lappaceum L. rind, for its therapeutic potential in ameliorating diet-induced metabolic risks mimicking metabolic syndrome. Male post-weaning outbred Sprague Dawley rats received a 60% high-fat diet (HFD), with and without the geraniin supplementation (10 and 50 mg/kg body weight), while the control group (ND) was fed rat chows for 10 consecutive weeks. Comparatively, HFD rats demonstrated elevated body weights, white adipose tissue depots (WAT), organ weights, triaylglycerol, renal and hepatic dysfunction biomarkers, insulin resistance, declined insulin sensitivity and percent of beta-cell function. A four-week in vivo geraniin treatment, particularly at 50 mg/kg body weight, exhibited significant therapeutic potential to safely mitigate obesity-induced metabolic dysfunction.
    Journal of Functional Foods 05/2014; 9. · 4.48 Impact Factor
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Geraniin, an ellagitannin found abundantly in many fruits, nuts, traditional Chinese medicine (TCM) and ayurvedic herbs, has been reported to possess numerous health benefits. This is the first study that elucidates geraniin, purified from the sub-tropical fruit Nephelium lappaceum L. rind, for its therapeutic potential in ameliorating diet-induced metabolic risks mimicking metabolic syndrome. Male post-weaning outbred Sprague Dawley rats received a 60% high-fat diet (HFD), with and without the geraniin supplementation (10 and 50 mg/kg body weight), while the control group (ND) was fed rat chows for 10 consecutive weeks. Comparatively, HFD rats demonstrated elevated body weights, white adipose tissue depots (WAT), organ weights, triaylglycerol, renal and hepatic dysfunction biomarkers, insulin resistance, declined insulin sensitivity and percent of beta-cell function. A four-week in vivo geraniin treatment, particularly at 50 mg/kg body weight, exhibited significant therapeutic potential to safely mitigate obesity-induced metabolic dysfunction.
    Journal of Functional Foods 07/2014; 9:173–182. DOI:10.1016/j.jff.2014.03.029 · 4.48 Impact Factor